Effects of Ginkgo (Gingko Biloba) on Retinal and Choroidal Ocular Tissue

NCT ID: NCT04448535

Last Updated: 2022-10-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-01

Study Completion Date

2022-08-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to understand the effect of Ginkgo Biloba oral supplements on retinal and choroidal ocular tissue.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study objectives are to:

1\. assess the changes from pre- to post- oral supplementation on retinal and choroidal thickness and blood flow, retinal oxygen saturation, ocular perfusion pressure, and retinal function

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Gingko Biloba

oral intake of gingko biloba for 4 weeks

Group Type EXPERIMENTAL

Gingko Biloba

Intervention Type DIETARY_SUPPLEMENT

oral intake of Gingko Biloba, 240mg/day for 4 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Gingko Biloba

oral intake of Gingko Biloba, 240mg/day for 4 weeks

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged between 20 - 55 years, inclusive
* Good general and ocular health
* Corrected visual acuity of 20/40 or better
* No gingko biloba supplementation within the last 3 months

Exclusion Criteria

* All significant ocular and any systemic disorders considered likely to affect the systemic or ocular vasculature
* History of ocular surgery, including refractive surgery
* Use of ocular medications
* Conditions where ginkgo supplementation is contraindicated
* Any eye or systemic disease that affect vision or refractive error
* Current smokers
* Subjects who are pregnant, breastfeeding, or planning conception
Minimum Eligible Age

20 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

State University of New York College of Optometry

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alexandra Benavente

Associate Clinical Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

SUNY College of Optometry

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1619383-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effects of Lutein on Visual Function
NCT03113864 TERMINATED NA
Carotenoid Supplementation and Normal Ocular Health
NCT02147171 COMPLETED PHASE2/PHASE3